Aug 2026· Critical reviews in microbiology· pp.
1-18
· 0 citations· 61 references
Medicine
TL;DR
This review collates the existing literature on zoonotic and bacterial origin AMPs, along with the matrix-disrupting and quorum-quenching enzymes, highlighting those which have proven to be effective in vitro/in vivo against clinical isolates from patients and identifies specific physiological and challenges that need to be overcome to take these alternative therapies to clinical practice.
Abstract
Medical biofilms are a significant problem in chronic diseases like diabetic ulcers that do not heal, infections of medical devices and CF. The extracellular polymeric matrix is a barrier to antibiotic penetration. In search of an alternative, approaches based on antimicrobial peptides (AMPs) and enzymes have been developed to tackle the multi-drug resistance. This review collates the existing literature on zoonotic and bacterial origin AMPs, along with the matrix-disrupting and quorum-quenching enzymes, highlighting those which have proven to be effective in vitro/in vivo against clinical isolates from patients. Enzymes (e.g. cellulase, alginate lyase, and dispersin B) can break down matrix components or block critical signaling molecules and can be seen to have strong synergy with antibiotics, whereas AMPs disrupt cell membranes and downregulate genes that encode biofilm-forming proteins. Our analysis reveals however, a key translational bottleneck: there were no clinical trials in human subjects identified despite strong preclinical evidence of activity. This review discusses these encouraging pre-clinical findings and identifies specific physiological and challenges that need to be overcome to take these alternative therapies to clinical practice.
This review aimed to synthesise the current evidence on PAP mechanisms, host-modulatory effects, and translational perspectives to present exciting avenues for clinical deployment of solutions in the early stages of development.
Faiyaz Ahmed, M. Alblaji· Probiotics and Antimicrobial...· 0 citations
Introduction: Infections caused by Enterococcus spp. remain a clinical challenge due to intrinsic antimicrobial resistance and strong biofilm-forming capacity. The increasing prevalence of vancomycin-resistant enterococci further restricts therapeutic options, reinforcing the need for alternative strategies such as ant...
Amanda dos Reis Correia, Angelica de Lima das Chagas, A. B. Silva et al.· Revista DCS· 0 citations
This review establishes a consolidated evidence base for the design of next-generation antimicrobial nanoformulations, highlights their potential to address biofilm-associated infections, and identifies key knowledge gaps and translation barriers that must be addressed to realize their therapeutic promise.
Praveen Kumar Annagowni, Renuka Gudepu, S. Dahariya et al.· Micro· 0 citations
This review provides an integrated overview of the molecular and genetic determinants governing biofilm development, including surface attachment, matrix biosynthesis, quorum-sensing networks, cyclic-di-GMP signaling, maturation, and dispersal.
T. Chakraborty, Madhuchhanda Chatterjee, Sayanika Das et al.· Infection, Genetics and Evol...· 1 citation
This review aims to provide a comprehensive and up-to-date overview of the molecular biology of S. aureus biofilms, biofilm-associated antimicrobial resistance, interactions with the host, polymicrobial interactions, and emerging therapeutic strategies, and to highlight the ongoing challenges and future directions in t...
Mohd. Saleem, A. S. Syed Khaja, Irfan Ahmad et al.· Molecular Biology Reports· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.